Declaratory Judgment Sought Over Allergy Patent

Law360, New York (April 20, 2007, 12:00 AM EDT) -- Breckenridge Pharmaceutical Inc. has asked a Maryland court for declaratory judgment, in an effort to protect itself from a possible patent infringement suit over its drug Allergy DN.

The lawsuit was filed Thursday, against Cornerstone BioPharma Inc. and J-Med Pharmaceuticals Inc., and comes in the context of ongoing negotiations between the parties, a Breckenridge spokesman said Friday.

The suit centers on U.S. Patent Number 6,270,796, issued in August 2001 and entitled “antihistamine/decongestant regimens for treating rhinitis.” Rhinitis is an inflammation of the lining of the nose,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.